30th April 2020
Sustainable encapsulation start-up offers help in the delivery of new COVID-19 molecules
Sphera Encapsulation is entirely dedicated to research and development in the field of sustainable encapsulation technologies.
Founded by specialists in the field of material and food chemistry, and incubated at the University of Biotechnology in Verona in 2016, the start-up has been active for three years. The company’s environmental mission can be seen in the complete sustainability of its formulas.
Sphera Encapsulation expertise lies in various different approaches for encapsulation of substances which may be helpful in the drug delivery of new COVID-19 molecules, to help make them more bioavailable.
The company is looking to partner with pharmaceutical companies working on a molecule for the COVID-19 disease.
ASK: Research contributors needed for CON-VICE study
University of Luxembourg needs European researchers to get in touch
OFFER: Funding available for COVID-19 research
Fondation Air Liquide are looking to fund European projects
ASK: Supporting the immunocompromised
Partners sought to advance neutralising antibody